tiprankstipranks
Advertisement
Advertisement
Cingulate files to sell 3.5M shares of common stock for holders
PremiumThe FlyCingulate files to sell 3.5M shares of common stock for holders
1M ago
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
Premium
TipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
1M ago
Cingulate announces U.S. patent notice of allowance
Premium
The Fly
Cingulate announces U.S. patent notice of allowance
1M ago
Cingulate Advances Capital Raise with Private Placement Financing
PremiumCompany AnnouncementsCingulate Advances Capital Raise with Private Placement Financing
3M ago
Cingulate Announces Private Placement and New Preferred Stock
Premium
Company Announcements
Cingulate Announces Private Placement and New Preferred Stock
3M ago
Cingulate Expands At-The-Market Equity Offering Capacity
Premium
Company Announcements
Cingulate Expands At-The-Market Equity Offering Capacity
3M ago
Cingulate price target lowered to $16 from $17 at Roth Capital
PremiumThe FlyCingulate price target lowered to $16 from $17 at Roth Capital
5M ago
Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment
Premium
Ratings
Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment
6M ago
CING Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CING Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100